(Q36968540)

17 August 2017

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis (English)

1 reference

17 August 2017

Gram-negative bacteria

0 references

0 references

7

Niels Høiby

0 references

Peter Diggle

object named as

Peter J Diggle

10

0 references

Terese L Katzenstein

8

object named as

Terese L Katzenstein

1 reference

17 August 2017

Tavs Qvist

1

1 reference

17 August 2017

David Taylor-Robinson

2

1 reference

17 August 2017

Elisabeth Waldmann

3

1 reference

17 August 2017

Hanne Vebert Olesen

4

1 reference

17 August 2017

Christine Rønne Hansen

5

1 reference

17 August 2017

Inger Hee Mathiesen

6

1 reference

17 August 2017

Niels Høiby

7

1 reference

17 August 2017

Rosalind L Smyth

9

1 reference

17 August 2017

Tania Pressler

11

1 reference

17 August 2017

5 October 2015

1 reference

Journal of Cystic Fibrosis

17 August 2017

1 reference

17 August 2017

15

1 reference

17 August 2017

3

1 reference

17 August 2017

380-385

1 reference

Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Risk factors for rate of decline in FEV1 in adults with cystic fibrosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Mycobacterium abscessus: a new antibiotic nightmare

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Update on the Burkholderia cepacia complex

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Standardisation of spirometry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

The environment and disease: association or causation? 1965.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Spirometric reference values from a sample of the general U.S. population

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Pathogenesis of cystic fibrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Random-effects models for longitudinal data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

The Environment and Disease: Association or Causation?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Copenhagen

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Pulmonary function between 6 and 18 years of age.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893021

Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey

4 September 2018

1 reference

12 December 2020

Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study

1 reference

12 December 2020

Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients

1 reference

12 December 2020

Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis

1 reference

12 December 2020

10.1016/J.JCF.2015.09.007

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

1 reference